Bhyan B, Jangra S, Kaur M, Singh H
A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight but beyond this, their weight regain plateaus, with individuals managing to keep off 25% of the weight lost to treatment, say researchers at the University of Cambridge
In the direct comparison of tirzepatide versus semaglutide, we observed CIs compatible with no difference and point estimates indicating a modest numeric advantage of semaglutide, if any, for reducing MACE, particularly among patients at high cardiovascular risk
These results highlight the significance of controlling LC intake because an excess of this dietary component raises TMAO levels, which in turn raises cardiovascular risk
Obesity is a significant OSA risk factor